TW202120483A - 放射性金屬錯合體之製造方法 - Google Patents

放射性金屬錯合體之製造方法 Download PDF

Info

Publication number
TW202120483A
TW202120483A TW109127152A TW109127152A TW202120483A TW 202120483 A TW202120483 A TW 202120483A TW 109127152 A TW109127152 A TW 109127152A TW 109127152 A TW109127152 A TW 109127152A TW 202120483 A TW202120483 A TW 202120483A
Authority
TW
Taiwan
Prior art keywords
ligand
water
reaction solution
radioactive metal
complex
Prior art date
Application number
TW109127152A
Other languages
English (en)
Chinese (zh)
Inventor
今井智之
桐生真登
井澤彰宏
Original Assignee
日商日本醫事物理股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本醫事物理股份有限公司 filed Critical 日商日本醫事物理股份有限公司
Publication of TW202120483A publication Critical patent/TW202120483A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C07F19/005—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 without metal-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
TW109127152A 2019-08-21 2020-08-11 放射性金屬錯合體之製造方法 TW202120483A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-151480 2019-08-21
JP2019151480 2019-08-21

Publications (1)

Publication Number Publication Date
TW202120483A true TW202120483A (zh) 2021-06-01

Family

ID=74660922

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109127152A TW202120483A (zh) 2019-08-21 2020-08-11 放射性金屬錯合體之製造方法

Country Status (9)

Country Link
US (1) US20220259160A1 (https=)
EP (1) EP4019502A4 (https=)
JP (2) JP7744828B2 (https=)
KR (1) KR20220047974A (https=)
CN (1) CN114269724A (https=)
AU (1) AU2020332618A1 (https=)
CA (1) CA3148288A1 (https=)
TW (1) TW202120483A (https=)
WO (1) WO2021033530A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022149578A1 (ja) 2021-01-08 2022-07-14 日本メジフィジックス株式会社 Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法
EP4442285A1 (en) 2021-11-30 2024-10-09 Nihon Medi-Physics Co., Ltd. Stabilized radiopharmaceutical composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670456B2 (en) * 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
WO2005084179A2 (en) * 2003-12-01 2005-09-15 Immunomedics, Inc. Improved method for preparing conjugates of proteins and chelating agents
WO2008009444A1 (en) * 2006-07-19 2008-01-24 Van Dulmen, Adrianus, A. Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide
AU2010326004B2 (en) * 2009-12-04 2016-04-21 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
DE102012019714B4 (de) * 2012-10-08 2022-04-28 Johannes Gutenberg-Universität Mainz Verfahren zur Herstellung von pharmakologischen Metall-Ligand-Konjugaten
US20140147381A1 (en) * 2012-11-29 2014-05-29 Gregory David Espenan 89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
JP2017503763A (ja) * 2013-12-03 2017-02-02 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｇｃｃ発現細胞を撮像するための化合物及び組成物
WO2017161356A1 (en) * 2016-03-18 2017-09-21 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
EP3609541A4 (en) * 2017-04-05 2021-04-07 Cornell University Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
JP2019151480A (ja) 2018-03-06 2019-09-12 富士ゼロックス株式会社 検知装置及び画像形成装置
US12351890B2 (en) * 2019-07-30 2025-07-08 Jfe Engineering Corporation Method for synthesizing zirconium complex

Also Published As

Publication number Publication date
EP4019502A1 (en) 2022-06-29
JP7744828B2 (ja) 2025-09-26
US20220259160A1 (en) 2022-08-18
CA3148288A1 (en) 2021-02-25
EP4019502A4 (en) 2023-08-16
CN114269724A (zh) 2022-04-01
JP2025116040A (ja) 2025-08-07
JPWO2021033530A1 (https=) 2021-02-25
AU2020332618A1 (en) 2022-02-24
WO2021033530A1 (ja) 2021-02-25
KR20220047974A (ko) 2022-04-19

Similar Documents

Publication Publication Date Title
Notni et al. A triazacyclononane‐based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography
JP2537502B2 (ja) １−置換−１，４，７−トリスカルボキシメチル−１，４，７，１０−テトラアザシクロドデカンおよび類縁体
Shetty et al. Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18 F-labeling study
JP2010532754A (ja) 前立腺特異膜抗原（ｐｓｍａ）の標識阻害剤、生物学的評価およびイメージング剤としての使用
Esteves et al. Remarkable inertness of copper (II) chelates of cyclen-based macrobicycles with two trans-N-acetate arms
JP2025116040A (ja) 放射性金属錯体の製造方法
Linder et al. Neutral, seven-coordinate dioxime complexes of technetium (III): synthesis and characterization
Chen et al. The syntheses and structures of ‘3+ 2’and ‘2+ 2+ 1’oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N, O donor ligand
Bhatt et al. Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89
Cowley et al. Acetylacetonate bis (thiosemicarbazone) complexes of copper and nickel: towards new copper radiopharmaceuticals
Procházková et al. Lanthanide (III) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yield
Lipowska et al. fac-99mTc/Re-tricarbonyl complexes with tridentate aminocarboxyphosphonate ligands: Suitability of the phosphonate group in chelate ligand design of new imaging agents
Procházková et al. DOTA analogues with a phosphinate-iminodiacetate pendant arm: modification of the complex formation rate with a strongly chelating pendant
Zhang et al. Synthesis and biological evaluation of a novel 99mTc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake
Lengacher et al. Organometallic small molecule kinase inhibitors–direct incorporation of Re and 99mTc into Opaganib®
CN103370084B (zh) 苯胺在肟连接的放射稳定化中的应用
WO2000043004A1 (en) 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors
CN1046857C (zh) 硫酸三异腈亚铜配合物及其制备方法
Francesconi et al. Synthesis, characterization and solid state structure of a neutral gallium (III) amino thiolate complex: a potential radiopharmaceutical for PET imaging
Pazderova et al. Complexes of cyclen side-bridged with a methylene-bis (phosphinate) group
US8067631B2 (en) Method of rapid methylation of alkene compound and kit for PET tracer preparation using the same
US11690923B2 (en) Multinuclear complexes and their preparation
Allali et al. Ethylenediamine-and propylenediaminediacetic acid derivatives as ligands for the “fac-[M (CO) 3]+” core (M= Re, 99mTc)
Cagnolini et al. Tetradentate bis-phosphine ligands (P2N2 and P2S2) and their Rh (III), Ni (II) and 105Rh Complexes: X-ray crystal structures of trans-[RhCl2 (L2)] PF6,[Ni (L2)](PF6) 2 and μ-O2SO2-[Ni (L5)] 2 (PF6) 2
HK40066248A (zh) 放射性金属络合物的制造方法